Pediatric liver tumors gobble up FDG

Article

FDG-PET imaging may have a place for staging primary hepatic malignancies in children.

FDG-PET imaging may have a place for staging primary hepatic malignancies in children.

Dr. Rajen J. Mody and colleagues at the University of Michigan Health System, Ann Arbor, imaged seven children with pathologically proven hepatic malignancies. Six of the seven exhibited abnormal FDG uptake. Liver tumor was confirmed in three patients who underwent partial hepatic resection and in one patient who had a brain biopsy. Uptake in one patient was due to necrotizing granulomas, and another patient's images were suboptimal due to noncompliance with fasting.

The researchers concluded that FDG-PET imaging in pediatrics is most useful to assess response to therapy, in following alfa fetoprotein-negative cases, and for detecting metastatic disease. The study appeared in Pediatric Blood & Cancer (published online Aug. 2 ahead of print).

Recent Videos
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Related Content
© 2025 MJH Life Sciences

All rights reserved.